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This paper reports finding from a nested qualitative study designed to elicit the views 
and perceptions of those who participated in a randomised controlled feasibility trial 
testing a non- pharmacological intervention, Respiratory Distress Symptom Interven-
tion (RDSI), for the management of the breathlessness–cough–fatigue symptom clus-
ter in lung cancer. Semi- structured interviews were conducted with 11 lung cancer 
patients, three caregivers and seven researchers involved in recruitment, consent, 
RDSI training and delivery and participant follow- up. Thematic analysis identified key 
considerations including: the importance of informed consent emphasising commit-
ment to completion of paperwork and raising awareness of potential sensitivities relat-
ing to content of questionnaires; ensuring screening for the presence of symptoms 
reflects the language used by patients; appreciation of the commitment required from 
participants to learn intervention techniques and embed them as part of everyday life; 
conduct of interviews with patients who decline to participate; and conduct of serial 
interviews with those receiving RDSI to further inform its routine implementation into 
clinical practice. This study will inform the development of a fully powered follow- on 
trial testing the hypothesis that RDSI plus usual care is superior to usual care alone in 
the effective management of this symptom cluster in lung cancer.
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1  | INTRODUCTION
Lung cancer symptoms, both physical and psychological, are often chron-
ic, resulting in significant burden, impaired physical and social function 
and poor quality of life (Yates, Schofield, Zhao, & Currow, 2013). In addi-
tion, lung cancer patients may undergo a range of treatment modalities, 
including surgery, chemotherapy and radiotherapy, with accompanying 
side effects adding to patient burden (Molassiotis et al., 2015).
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Compared to other types of cancer, the distress associated with 
symptoms arising from lung cancer has been reported as the most 
intense (Schofield et al., 2008). Several studies have identified the 
presence of a respiratory symptom cluster in patients with lung can-
cer showing close associations among breathlessness–cough–fatigue 
(Cheville et al., 2011; Molassiotis et al., 2011). This interacting symp-
tom cluster, called Respiratory Symptom Distress Cluster was found 
to play a central role in patients’ symptom experiences within the lung 
cancer population.
The randomised controlled trial (RCT) is a central tenant of evi-
dence based healthcare (Treweek et al., 2015). Significant challenges 
have been experienced in previous trials with lung cancer patients. 
These have been the result of patients’ poor performance status and 
high symptom burden with complex symptomatology, which can lead 
to difficulties in study recruitment, retention and implementation 
of non- pharmacological interventions (Jordhøy, Kaasa, Fayers, 
Underland, & Ahlner- Elmqvist, 1999; Zhao & Yates, 2008).
Methodological literature is almost exclusively statistical and epi-
demiological, and very little of it is concerned with conduct or the 
particular demands that trials put on researchers and participants 
(Donovan et al., 2002). When feasibility testing an intervention it 
is crucial to explore the views and experiences of all stakeholders. 
Consideration should be given to issues that might make a non- 
pharmacological intervention more appropriate, viable, and achievably 
integrated into standard practice while responding to policy drives 
for service users to be more involved in research and health service 
development (Department of Health, 2006). Nested qualitative stud-
ies, using semi- structured interviews within trials are essential as they 
provide insight into such issues.
This paper reports the findings from a nested qualitative study, 
part of a RCT which aimed to evaluate the feasibility and acceptabil-
ity of a non- pharmacological intervention, the Respiratory Distress 
Symptom Intervention (RDSI), plus usual care versus usual care alone 
for the self- management of breathlessness–cough–fatigue symp-
tom cluster in lung cancer. The main results of the RCT  feasibility 
trial are reported elsewhere (Yorke et al., 2015). RDSI had three core 
components focusing on, (1) breathing techniques, (2) cough easing 
techniques and (3) acupressure. Furthermore, patients were given a 
supplementary symptom experience information pack collated from 
existing resources (see Box 1). Patients  randomised to the control 
group received usual care alone (see Box 2).
BOX 1 Components of respiratory distress symptom 
intervention (further details regarding RDSI are pro-
vided in Yorke et al., 2015).
i) Diaphragmatic breathing
Controlled diaphragmatic breathing techniques
ii) Acupressure
Patients were taught a number of acupressure points: L7, L9, 
LI4; ST 36; CV 21 and 20.
Patients were taught to select any of these points in any com-
bination and to apply pressure at least twice a day, applying 
steady firm pressure for 1 min to each point with the thumb or 
middle finger, releasing the pressure slowly after the minute. 
They can use these points more frequently if they so wish.
iii) Cough easing techniques
i. Increase awareness
ii. Apply controlling techniques
Once they are aware of how it felt just before they cough or 
clear their throat they were asked to apply one of the three 
following techniques: Take a sip of water; Sniff then swallow; 
swallow.
Patients were told that it may take a number of consecutive 
attempts of the controlling techniques for a few seconds of 
relief before the urge to cough returns. The key is to perse-
vere—if the urges to cough returns just repeat again.
Alongside Supplementary Written Information giving 
practical advice about:
i) symptom experiences and communication strategies
ii) Vocal hygiene
iii) Sleep hygiene
iv) Activity management/energy conservation strategies
v)  Anxiety management techniques (such as the ‘calming 
hand’)
vi) Carer support
BOX 2 Components of best supportive usual care 
(Standardised according to Wagland et al., 2012).
Symptom management followed a detailed assessment of 
each patient’s needs to rule out other possible causes for the 
symptoms and to assess the impact of comorbidities. Social 
circumstances were also considered and appropriate referrals 
made (e.g. occupational therapy, physiotherapy, social servic-
es, psychological services).
i. Breathlessness—according to degree of breathlessness
– Morphine
– Oxygen
– Benzodiazepines
– Ventolin or saline
All patients were given the Macmillan Cancer Support booklet 
‘Managing Breathlessness’
ii. Cough—according to severity
– Morphine (severe cough only)
– Codeine linctus
– Simple linctus
iii. Fatigue
– Steroids (if appropriate)
All patients were given the Macmillan Cancer Support booklet 
‘Coping with fatigue’.
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The aims of the nested qualitative study reported here were:
1. To elicit the views and perceptions of patients and their carers 
who participated in the RCT regarding their reasons for con-
senting to participate, their experiences being a research par-
ticipant, the RDSI package and the outcome measures used.
2. To elicit the views and perceptions of the researchers involved 
regarding the process of recruitment, consenting and randomisa-
tion, RDSI training and delivery, participant follow-up and their 
general experiences of being involved in the trial.
2  | METHODS
The study sites included two specialist cancer hospitals and nine other 
NHS hospitals in the northwest of England. Approval for the conduct 
of the main RCT and nested qualitative study was provided by the 
National Health Service ethics and participating hospital governance 
committees (reference: 12/NW/0090). All participants (patients, car-
ers and researchers) provided written informed consent to take part in 
interviews discussed here.
2.1 | Sampling
2.1.1 | Patient and carer participants
A purposive sample consisting of participants, who at trial entry had 
indicated an interest in taking part in interviews, was approached. 
Criteria for selection included being a trial participant; randomised 
to either the intervention or control group and representative of the 
three cancer treatment groups as per stratified randomisation: (1) No 
further active cancer therapy; (2) Post- curative treatment or (3) On 
palliative cancer therapy follow- up. We aimed to recruit five patients 
in each treatment group and their carers (although interview partici-
pants were not required to be dyads).
2.1.2 | Research staff
A focus group discussion was arranged with the trial specialist prac-
titioners who participated in recruitment and intervention delivery, 
complementary therapists who taught the intervention to the special-
ist practitioners and the research associates whose main role was to 
recruit and follow- up trial participants.
2.2 | Data collection
Semi- structured interviews with patients and carers were undertaken 
by two research associates (JE, JW) working on the main feasibility 
trial and both experienced qualitative researchers. Patients and par-
ticipating carers were requested to be interviewed separately. The 
interviews were guided by an interview schedule which focused on 
the following key issues: reasons for taking part in the trial; gen-
eral experiences of taking part in the trial; patients’ experiences of 
receiving the intervention; patient experiences of being in the control 
group; and carers’ experiences of taking part in the trial. Interviewers 
were also free to explore other issues as they arose. Demographic and 
clinical data were collected either from the patient (age, gender, mari-
tal status) or from the medical records (i.e. WHO performance status, 
type of lung cancer and cancer treatment group). Participants were 
provided with the option to have interviews conducted face- to- face 
at a mutually convenient venue or a telephone interview. Interviews 
were recorded and transcribed verbatim.
The focus group with project staff was directed by a topic guide organ-
ised around the following key topics: general experience of taking part in 
the trial; process of recruitment, consenting procedure and randomisa-
tion; experience and views regarding the training for intervention deliv-
ery; experiences and views regarding delivery of the intervention; overall 
conduct of the trial and their participation in the trial and final recommen-
dations for the main trial. All focus group participants provided informed 
written consent for the focus group discussion to be audio- recorded and 
subsequently transcribed verbatim, anonymity being assured.
All patient and carer participant interviews and the project staff 
focus group were conducted following completion of their study 
involvement.
2.3 | Data analysis
A modified version of thematic analysis, a method for identifying, 
analysing and reporting patterns within data (Braun & Clarke, 2006), 
was undertaken using interview and focus group schedules as a guide 
for categorising data interviews and the focus group. The researchers 
familiarised themselves with the data through listening to the audio- 
recordings and checking and re- reading the transcripts. Data analysis 
was conducted by the two researchers who had undertaken the inter-
views and in collaboration with the Chief Investigator. Throughout 
the analysis the researchers met regularly to discuss the analysis.
3.  | RESULTS
3.1 | Patient and carer participant interviews
A total of 11 patients (six women; five men) and three carers (two 
women; one man) participated in interviews. Six patients had been ran-
domised to receive the intervention and five to the control group. Six 
patients had received treatment for their lung cancer with post- curative 
intent and the remaining five were receiving palliative cancer therapy 
follow- up. No patients who consented to be interviewed were in the 
no active cancer therapy group. Two of the three carers who participat-
ed were female and all were either a spouse or partner of the patient. 
Detailed socio- demographic and clinical data are presented in Table 1.
All but two of the interviews took place in the patient’s home, the 
remaining two by telephone. Ten patients and two carers provided 
consent for the interviews to be audio- recorded. One patient and their 
carer did not consent to the interview being recorded but did consent 
to field notes being taken. Unfortunately, due to a malfunction of the 
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audio- recorder, the two telephone interviews were inaudible; there-
fore, in- depth field notes were used for analyses.
The analysis focused on patients’ and carers’ views and experienc-
es regarding their involvement in the trial. Five themes were extracted 
from the data and centred on the study aims. These are presented 
below supported by indicative quotes shown in Table 2.
3.1.1 | Reasons for taking part in the trial
Participants had varied reasons for taking part in the trial. Two 
patients and one carer had the expectation that being in the trial might 
help ease troublesome symptoms, such as cough and fatigue, which 
were perceived as receiving little attention from healthcare profes-
sionals. Seven patients expressed no expectations whatsoever and 
one patient and one carer described being sceptical about how effec-
tive taking part would be. Two patients felt taking part would allow 
them to gain further knowledge of their symptoms and lung cancer. 
There was also the perception that patients felt somewhat neglected 
by their clinical teams and left to “get on with it” and participating in 
the trial may, therefore, offer an avenue for additional support.
3.1.2 | Patients’ general experiences of taking part 
in the trial
Patients in both study arms reported gaining a greater understanding 
and knowledge of their illness and symptoms, especially in relation to 
the presence of symptoms post- cancer treatment. The support from 
the research team was valued, particularly by those living alone. There 
was a feeling that they were continuing to be monitored through partic-
ipation in the study, which provided them with a sense of reassurance.
Patients expressed varying degrees of difficulty in completing the 
questionnaires with three out of the 11 patients describing them as 
repetitive and overwhelming. In contrast, two patients appeared to 
have benefited from completing them as it tended to legitimise their 
symptoms or help them accept the realities of their disease. All patients 
appeared to be reassured with the knowledge that the symptoms were 
relatively common among lung cancer sufferers and were not unique 
to them. Patients stated that some of the questionnaires were not rel-
evant as they referred to their lung cancer—yet they believed their lung 
cancer to have been cured and they were no longer suffering from the 
disease. There was a general perception that the questions asked in 
the study questionnaires could be upsetting to patients and their car-
er’s, however, no patients expressed feeling upset at being asked these 
questions themselves. One carer felt some questions were intrusive 
but understood why they were being asked. For this reason, additional 
support may be required when considering future trials.
One participant explicitly stated they found the Macmillan booklets 
and Supplementary Information very useful commenting on the CD 
in particular. However the general consensus was that far, too much 
information was supplied with patients finding it difficult to navigate 
around the various materials. Four patients appreciated the support in 
completing the questionnaire and felt they would have been less likely 
to complete them without it. Unfortunately, one patient did not recall 
receiving any information. Despite this, all patients in both groups were 
glad to have taken part in the trial and would recommend it to others.
3.1.3 | Patients’ experiences of receiving the 
intervention
While initially two participants expressed scepticism that the inter-
ventions would work, they soon perceived a greater sense of control 
in their ability to manage their symptoms. Two interviewees reported 
immediate benefits from the intervention; the remainder discussed 
how benefits actualised over some time. Patients reported being 
able to undertake activities they had not been able to achieve since 
their diagnosis. Patients did not find the techniques restrictive, rather 
they used them as and when they felt the need. The only barrier to 
practising the techniques appeared to be when patients were feeling 
T A B L E  1   Socio- demographic and clinical data of the sample
ID Gender Age Treatment Group WHO PS Trial Arm
Carer 
 interview Gender
216 Female 61 Post- curative intent treatment 2 Control No
217 Male 63 Post- curative intent treatment 1 Intervention Yes Female
303 Female 65 Post- curative intent treatment 2 Intervention Yes Male
312 Female 70 Palliative cancer therapy follow- up 1 Control No
315 Female 64 Palliative cancer therapy follow- up 1 Intervention No
317 Male 78 Post- curative intent treatment 1 Intervention No
318 Female 63 Palliative cancer therapy follow- up 2 Control No
408 Male 64 Post- curative intent treatment 0 Control Yes Female
409 Female 63 Palliative cancer therapy follow- up 1 Intervention No
505 Male 77 Palliative cancer therapy follow- up 1 Control No
604 Male 78 Post- curative intent treatment 2 Control No
WHO PS, WHO Performance Status: 0 = fully active; can’t carry out heavy physical work; 2 = up and about more than half the day; 3 = in bed or 
a chair for more than half the day; 4 = in bed or a chair all the time and need complete care (Trial inclusion criteria WHO PS 0–2).
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T A B L E  2   Supporting quotes from patients and carers
Reasons for taking part in the trial
Expectations “Just I thought I would…it would help me with my breathing, and stuff like that. Which it did, because I read the book there, and 
it did help me a lot.” (216, Patient)
“No expectations at all and was happy to play it by ear.” (317, Patient)
‘just to basically try and improve the lot that she’s got, that she’s been left with, if you like. If you can improve her breathing, 
which to me it did just a little, you know…but, no, it did meet them and more (303, Carer)
“Getting more knowledge about fatigue and breathlessness.” (408, Carer)
General experiences on taking part in the trial
Understanding “Yes, because you explained it to me… in layman’s terms.” (315, Patient)
“The reason I joined the trial is because of the way things were explained – it was a better explanation than anyone has given me 
before…” (408, Patient)
“Yeah, because it was treatment as normal and then this was extra that you wouldn’t necessarily have had.” (303, Patient)
Completing 
questionnaires
“Couldn’t have completed the questionnaires without the help of the support team.” (315, Patient; 318, Patient)
“Found some off the questions very repetitive and didn’t see the point of them. “Found some questionnaires difficult to fill 
in- had to have help.” (318, Patient)
“I find it difficult to self- assess and that wouldn’t apply to every person but if it says how to…on a scale of one to ten, however, I 
found it difficult to assess…” (303, Patient)
“There was one point, it wasn’t upsetting, but it was a reality check. It was a question where I thought, oh gosh, yes.” (303, Carer)
“Because of the type of illness B [patient’s name]’s got, I found some of the questions a little bit hard to answer, because they 
weren’t really relevant to somebody who was more severe with the illness…” (217, Carer)
“My first reaction was to get through it. The questionnaires made you think……some of the questions were quite searching….
some were intrusive.” (408, Carer)
“In my opinion the one thing that probably was the paperwork, from my point of view I like the hands on, more so than sitting 
there filling in forms. That’s probably why I enjoyed doing the work is love hands on, and I think as far as filling forms in, it’s not 
my thing” (303, Carer)
Support from 
the research 
team
“Yes, there was nothing wrong with the support at all, and we were helped whenever we needed to be helped.” (604, Patient)
“Yes, in a way, because you’ve got somebody to fall back on. If there’s something playing on your mind, or you’ve got a problem 
with something, you know there’s somebody there at the end of the phone that you can phone up.” (315, Patient)
“Absolutely fantastic – wonderful people.” (317, Patient)
Benefits of 
participating
“… you learn to understand things a lot better.” (315, Patient)
“I found out a lot more about the cancer, also after the cancer, the way I’d been feeling, and it helped me a lot I found out a lot, 
really, about things I didn’t understand before. Yes, because I’m tired all the time, and that explained it. The coughing, which it 
explained it…” (216, Patient)
“Keeping an eye on you…checking how you were…” (318, Patient)
“Checking up on you …seeing how you are.” (505, Patient)
“Of course there are benefits - it made me realise what people are going through and that people do understand.” (408, Patient)
“Yes, if it’s going to help, and it’s going to help other people.” (217, Carer)
“Yes, because it has been a benefit to…, so I think people should try it, whether they find it doesn’t help them…but unless you try 
it you don’t know, do you?” (217, Carer)
“Should have this course when people need it.” (408, Carer)
Experiences of receiving the intervention
Thoughts on 
being 
randomised to 
the NI
“I think we were pleased really weren’t we? Extremely pleased, yeah. Because we thought oh yeah we can actually do something 
rather than being in the controlled group, because I’ve been in the controlled group before and it’s just…they send you surveys 
and what have you but you feel as though you’re actually in control of your illness.” (303, Patient)
“I was quite pleased actually. It’s not as though…no, how am I going to put this without sounding awful…before these exercises, I 
felt as though I’d just been left to get on with it, kind of thing. But when I was told I was going to be taught how to help myself 
with the breathing, I was really pleased.” (217, Patient)
“Shocked, because I honestly thought when we were approached it might be the other group, the smaller group, which would be 
just paperwork. But, when we were actually put on this one I thought that it could only be good, and I think it was.” (303, Carer)
“Yes – pleased….like I said before, because the more people are paying attention to him, the more I’m comfortable with that.” 
(217, Carer)
Breathing 
techniques
“Well, the actual breathing exercises have been brilliant. They’ve really helped control it. ….. And I got it under control a lot 
quicker than I was doing before.” (217, Patient)
“But I think for me it was more about the breathing that helped me overcome the sense of panic sometimes really and just level 
myself down. loved stretchy man…I think that was the favourite one.” (303, Patient)
“Yes, it was just the main part was getting to breathe in, but your stomach, and your bottom was supposed to go out… that is 
what I found difficult to begin with.” (315, Patient)
“I think it’s been a good benefit to me and I’m still doing it…I do feel better when I’ve done the breathing exercises. It calms me 
down and my breathing does seem easier.” (303, Patient)
(Continues)
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too unwell. All six participants described benefiting from practising 
breathlessness techniques, which in turn helped with associated anxi-
ety. Two patients made a specific reference to the stretchy man tech-
nique expressing how they enjoyed or favoured this one in particular.
While difficult to grasp at first, the four patients who used the acu-
pressure technique reported they found it beneficial and unobtrusive. 
Not all points taught suited all patients. It was felt that an addition-
al reminder session would have been helpful as one patient admit-
ted stopping due to feeling unsure they were doing it correctly. For 
patients who suffered from cough, the easing techniques appeared to 
be beneficial at times. In addition, there were unexpected benefits. 
The breathing techniques allowed one patient to forego her “sprays,” 
which she claimed she no longer needed. One patient, who had pre-
viously experienced great pain and anxiety when opening her bowels, 
was able to apply the breathing exercises to alleviate constipation and 
reported immediate benefit.
3.1.4 | Patients’ experiences of being in the 
control group
Of the six patients randomised to the control group only one specifically 
expressed disappointment at this. Patients understood the process of 
randomisation and the necessity of having two groups were happy to 
have taken part and did find it beneficial. All control group participants 
stated they learnt a lot about their condition through the processes of 
informed consent. Reading the questionnaires also helped to legitimise 
their symptom experience and provided a sense of reassurance that 
other patients were likely to be experiencing similar symptoms.
3.1.5 | Carers’ experiences of taking part in the trial
All three carers interviewed were pleased to have taken part in the 
trial. Like patients, they appeared to gain a greater understanding of 
the symptoms experienced by their relative/friend by reading the 
study information provided and completing the questionnaires. They 
appeared to be reassured by the contact with the research team, 
which they felt was a form of monitoring their relative/friend’s illness. 
One carer took on an active role in encouraging and helping his spouse 
undertake the intervention techniques. Carers found the question-
naires repetitive, somewhat intrusive and at times not relevant since 
their partner did not have as severe an illness as the questionnaires 
implied. Like patients, carers felt the intervention should be offered to 
patients regardless as to where people were in their cancer treatment 
and post- treatment journey. This would enable people to draw on the 
knowledge and skills learnt as required. All three carers interviewed 
stated that they would recommend others participating in any future 
study, since it was felt that it helped their relative/friend.
3.2 | Project staff focus group
The focus group was held in a private meeting room and was attended 
by the chief investigator (Chair), the lead complementary therapist 
(conducted intervention training and delivery), two complementary 
therapists (conducted intervention delivery); two specialist practition-
ers (one physiotherapist and one clinical nurse specialist who conduct-
ed recruitment and intervention delivery) and two research associates 
(conducted recruitment and study follow- up). The focus group lasted 
Acupressure “But I think I get a bit boring where I tried to do the same pressure points and I didn’t try the knees. What worked for me were 
the ones on the wrists and the ones on the thorax and once you get into it and once you get the hang of it…they’re not hard to 
do…and it’s quite hidden from other people…you can sit with your hand under your sleeve on the pressure point on your wrist 
and nobody knows what you’re doing but I felt the benefit that way as well.” (303, Patient)
“The actual pressure points, the ones on my hand and on my wrist, it was a nice feeling afterwards, yes…. It’s just, it’s funny, it’s 
difficult to describe, you just feel relaxed. It’s as though it takes all the tension out of your arms. But the ones on the leg, and 
the sternum, no, they didn’t do anything for me.” (217, Patient)
“You know, even when I’m sitting here, or whatever, and I’ll be like this so (referring to the wrist and hand points)…but didn’t like 
the one on the leg.” (315, Patient)
Cough easing “I did the swallowing again with the water and, yeah, they helped. But I think for me it was more about the breathing that helped 
me (303, Patient)
“Sometimes it worked, other times I would take a sweet or something.” (315, Patient)
Additional 
positive effects
“No, because…I’ve started going fishing again, and that was the ideal place to do it, just sat at the side of the pool, because you’re 
in an upright chair anyway, and it’s the perfect place to do it.” (217, Patient)
“You can do it while you’re sitting in the bus shelter on your way to bingo.” (315, Patient)
“I think you feel as though you’re actually doing something to help yourself. And that must have well it does have a positive 
effect on your treatment.” (303, Patient)
Experiences of being in the control group
Written 
information/
CD
“Found information very useful, especially the CD–it helped with breathing found it very calming - found the voice very 
soothing.” (318, Patient)
“Well, sometimes I find these sort of things, these little booklets, overdone, if that’s the word. It’s what is told in 27 pages could 
probably be told in just as easily seven pages So, at the end of the day one has to ask the question, has it done me any good. 
Because, by the time I’d got to the 27th page I’d forgotten what the first page said, and I’m no longer 25 years old.” (604, Patient)
T A B L E  2   (continued) 
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Table 3 Supportive quotes from focus group with research staff
Process of recruitment, 
consenting and 
randomisation
Screening questions for symptoms
“… the different doctors gate keeping their patients…some doctors would let you screen the notes, other doctors 
wouldn’t even let you put a sheet on the front of the notes to remind them of the eligibility criteria; so a lot of 
variability in being able to recruit from different consultants.” (P1)
“I think in terms of identifying some of the patients, when you’ve met them before we’ve found there’s some people 
that actually deny the symptoms that they’ve got and you know that they’re breathless and you can hear them, but 
they say, no, no, I’m fine.” (P2)
“They’ve [symptoms] become normalised, because we had quite a few where it wasn’t bothersome to them- they’ve 
adjusted their life around their symptoms.” (P1)
Inclusion criteria too restrictive
“Especially in the palliative and the no further treatment groups because even with treatment you would expect those 
patients to continue to have these symptoms. The treatment doesn’t relieve them of the symptoms so making them 
wait until they’ve been eight weeks on the TKI or four weeks post other treatments it felt like, why? We want to 
demonstrate the benefit of this intervention; these patients are going to continue. We’re not expecting these 
treatments to cure them. They are going to continue to have symptoms and symptoms relating to the treatment as 
well, never mind the illness that they’re having the treatment for.” (P1)
Participant support throughout trial participation
“I think the ones that said, no, I’m fine, I tended to think that they were wanting to go on to talk about other things in 
their lives and trying to get…and were more needy in that way, psychologically. Then almost thinking, well, I might be 
completely wrong, but it was like, they agreed to the study because they’re going to get this extra intervention and it’s 
not always…” (P2)
“So it’s about attention and support.” (P3)
“I think it did reveal a lot of unmet needs. I can remember one of the consultants who we were recruiting from said, oh, 
how lovely we’ve got this study. Now we’ve got something to offer our patients. That really upset me. Well, actually 
you’ve got a lot of services in your area that you could be referring to now and you’re not using them. It upset me the 
number of patients that did have significant unmet needs that this study was attending to some of them.” (P1)
“We had a couple of patients who refused because they were actually blind or partially sighted and…one in particular, 
felt that because her son had said he would help her to fill them in, but because the diary was a daily diary et cetera, 
she felt it was too much to ask him to do. So we excluded patients, not intentionally, but we are excluding some 
patients, aren’t we?” (P4)
“We also had somebody who wanted to be a carer but was dyslexic and just said, “no, any blood you want, fine, but 
paper, no”. So that’s perhaps something to think about.” (P5)
Carer involvement
“There is a sense of protectionism because I had one patient I phoned the other day regarding the follow- up and she 
said, “I think he’s too ill now to participate. He’s very poorly, he’s very confused now.” So the sense of protection is in 
that part and sometimes we went to do the follow- up, a telephone follow- up, then it would be the carer or it could be 
not necessarily in the trial, but a daughter or a son or somebody who answered the phone. They would say how they 
were rather than you talk one to one with the patient.” (P4)
Completing the Paperwork
“It’s quite challenging and time- consuming isn’t it, for them. I find a few of my participants have found it difficult to 
actually understand the questions because their literary levels vary so much. So you have to ask them how easy, well, 
‘it was easy because you’ve helped me, but if I had to do it, I couldn’t do this, because I don’t understand the 
questions’.” (P4)
“I had a husband and wife team who seemed quite keen but they dropped in and out and then finally dropped out 
because they thought the paperwork was too much. Having to attend to it every day kept drawing their attention 
back to it [illness}. One of them was okay with it, but the other one said, no.” (P7)
“I had a relative who got really emotional and got so emotional that I was, like, if it’s going to distress you, feel free if 
you want to come back to it. I just thought it was hard then to teach all the techniques while she’d got upset initially.” 
(P1)
“… it [completing the paperwork] forces them to think about things that they have not thought about and although 
personally I would try and prepare them ‘there may be some things that you may not expect, but please tell us if it’s 
too distressing’.” (P4)
“I’ve had actually patients refuse on that grounds to do it, because it does not apply to me. ‘No, this isn’t applicable to 
me. I haven’t got lung cancer anymore.’”(P4)
“I think one of the main difficulties is quite a few of these patients have had surgery, chemotherapy and/or radiothera-
py and they believe themselves to be cured. So a lot of the questions it says, the treatment for my lung cancer, and 
they turn round and they say, I have not got lung cancer anymore.” (P6)
(Continues)
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1 h and 10 min and was transcribed verbatim. Data are presented in 
four themes representing the study aims and evidenced by indicative 
quotes shown in Table 3.
3.2.1 | Process of recruitment, consenting and 
randomisation
Several key points were identified regarding the process of recruit-
ment. At a number of research sites recruitment was dependent on 
the doctors identifying potential participants. It was suggested that 
some doctors were acting as gatekeepers and that the screening and 
recruitment process varied across the sites. Those involved in the 
recruitment process reported that the inclusion/exclusion criterion 
was too restrictive. As a result, it was felt that many patients who 
may have benefited from participation in the trial were excluded. This 
was found to be particularly relevant for patients who were within 
4 weeks of chemotherapy or 8 weeks of commencing tyrosine kinase 
inhibitors. The general perception was that patients should be able to 
receive the intervention regardless of where in the illness trajectory 
they were.
There was a sense that many patients who were identified as being 
suitable to participate tended to deny their symptoms, having become 
normalised and adjusted their lives accordingly. These patients when 
asked about their symptom experience responded that they were “not 
bothered” by their symptoms and therefore were ineligible. There was 
also a general sense that some patients participated because they would 
be receiving increased attention and support that may have been lack-
ing from the clinical team. This view was also expressed by clinicians—
the study was viewed as a way of helping to meet perceived unmet 
patient needs. The time frame between providing consent and receiving 
the first intervention (suggested 1 week) was found to be problematic, 
as some patients became ill during that period whilst others had prob-
lems fitting in the intervention visits around other appointments.
3.2.2 | Experiences and views regarding the training 
for intervention delivery
The specialist practitioners received two training sessions delivered 
by the lead complementary therapist. A training manual was also pro-
vided and ongoing telephone support was available, if required. The 
training and review sessions were generally well received and staff 
found the Good Clinical Practice (research conduct and ethics train-
ing in the UK) training beneficial and increased their knowledge and 
skills particularly regarding consenting and the research process. The 
specialist practitioners found the training manual was important with 
regards to supporting the different techniques, although it was felt 
that some key information was missing. In particular, it was felt that 
the role of physiotherapy, physical activity and exercise was under-
played in the fatigue information section.
Given that those delivering the intervention were from differ-
ent disciplines with different levels of expertise presented an issue, 
particularly at the beginning of the trial, was how to use the infor-
mation provided (Supplementary Information Booklet, Macmillan 
Managing Breathlessness and Coping with Fatigue). It was highlighted 
that they would have benefited from a better understanding of when 
and how to use the information booklets, although it was noted that 
the Supplementary Information Booklet provided the opportunity to 
talk about other issues (other than their normal clinical practice) and 
patients may benefit from this.
3.2.3 | Experience and views regarding the 
delivery of the intervention
The delivery of the intervention varied across sites for example at one 
site all patients attended the hospital for the intervention whilst at a 
second site, patients received the intervention at home. The study 
protocol did not stipulate where the intervention was to be deliv-
ered and sites had the choice of delivering it at the hospital or in the 
Experience and views 
regarding the training for 
intervention delivery
“I know there’s a range of different practitioners” skills around the table, we’re not all from the same health profession, 
so we’ve all got different levels of expertise. Some of us would focus more on some aspects of their presentation than 
others. It was difficult to know if I was going to go into parts of the information booklet that would be relevant for my 
particular skill set” (P1)
“I think maybe for training the trainers if we could have had a better baseline of how we were using the supplementary 
information that would have assisted treatment fidelity for the intervention.” (P1)
“I was fairly new to it. I’d done hand massage in the past things like that. I’d never actually done the acupressure points. 
I did have to try it on myself and my husband before so I could gain confidence, but no, they all accepted that and it 
was quite good really.” (P2)
Experiences and views 
regarding delivery of the 
intervention
“I talked about the practicality of how it works because I learnt very quickly that people appreciated them when they 
actually understood there was a purpose behind it.” (P6)
“So like the woman who thought her lungs were this big, when we sort of went, oh, you know, you’re stretching and 
lifting and filling up those bags in your lungs, she really got that idea.” (P6)
“I had some patients who asked a lot more questions about the information booklets and went a lot more off topic than 
others. One of my last ladies in the study … said, I’ve learnt more in the two hours of your visits than I have in the 
whole of my illness about taking care of myself.” (P1)
Again, because that needs to be there earlier on to give people the skills, that’s what these interventions are about.” (P1)
Key: P1 (Physiotherapist) and P2 (lung cancer nurse specialist): Specialist Practitioners responsible for intervention delivery. P3 (clinical lead), P4 (trained 
therapist) and P7 (trained therapist and registered nurse) Complementary Therapists, responsible for training of Specialist Practitioners and intervention 
delivery. P5 and P6: Research Associates responsible for day- to- day trial running, recruitment, consent and follow- up.
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community; specialist practitioners found the latter more conveni-
ent for patients. Participants also stated that it was challenging to fit 
the intervention training session around other commitments such as 
hospital and personal appointments. One specialist practitioner sug-
gested that a video element may have been useful. Generally, those 
delivering the intervention reported that the experience had been 
quite educational for patients and carers as they benefited from being 
able to see how to do the techniques and understood the dynamics 
of how they worked.
Focus group participants suggested that the level of involvement 
of carers varied, but where they were involved it was perceived that 
they played a key role in encouraging patients to practice the different 
intervention techniques. However, there was also a sense of protec-
tionism identified from the carer. This was especially evident in some 
circumstances when the researcher would conduct a follow- up call yet 
the carer would speak to the researcher on the patient’s behalf.
Specialist practitioners expressed some difficulty taking on the 
research role as the requirements of the trial differed slightly to what 
they would do in normal clinical practice. It was noted that some 
health professionals may be tackling the sessions from a physiological 
perspective whereas others may tackle it from a psychological level, 
but the key focus was on optimising participant self- management of 
symptoms. In addition, it was felt that different health profession-
als may have focussed differently on different components of the 
intervention.
It was agreed that several questionnaires included in the 
participant study packs asked directly about lung cancer symp-
toms—yet for those patients who believed they were cured 
following treatment made questionnaires difficult to complete 
as they could not relate to the questions and in some instanc-
es prevented people for taking part in the trial. Completing the 
paperwork also brought patients/carers focus back to the dis-
ease, which was viewed as evoking distress as it forced them to 
think about issues they may not have previously thought about 
or chose not to.
4  | DISCUSSION
Feasibility studies of complex interventions are important to test 
not only potential effectiveness but also to assess acceptability and 
practicality of the intervention, and to refine and improve it prior to 
conducting a fully powered trial. This nested qualitative study pro-
vides support for the intervention and development of a subsequent 
trial while highlighting aspects that require further development. In 
this qualitative study, we elicited both general and specific feedback 
from trial participants (patient and carers) and study staff involved 
in all aspects of the trial including recruitment, intervention training 
and intervention delivery. This approach provided a broad range of 
experiences, views and expectations with recommendations from key 
stakeholders.
It has been previously suggested that eligibility criteria for trials 
of supportive care intervention for people with lung cancer should 
be broad in an attempt to counteract relatively low recruitment rates 
and high attrition rates (Schofield et al., 2008). In the current trial, 
patients were excluded if they had a chest infection or had received 
chemotherapy/radiotherapy within the previous 4 weeks. However, 
all interviewed patients and carers felt that the intervention should 
be available for patients when they most needed it and regardless 
of current or recent cancer treatment. This view was also shared by 
the research staff who found the eligibility criteria to be “restrictive.” 
This perhaps reflects the positive views held by participants about the 
intervention. It is known that patients’ experiences of symptoms such 
as breathlessness, cough and fatigue are influenced by recent infec-
tions and cancer treatments and therefore may impact on the results 
of studies designed to ameliorate such symptoms. As such, eligibili-
ty criteria will remain the same for the subsequent trial, where RDSI 
effectiveness will be tested. Following successful completion of the 
trial, RDSI will be recommended for people with symptoms regardless 
of previous infection or stage of cancer treatment.
During the focus group research staff indicated that potential par-
ticipants were missed because the patient had “adjusted their life” and 
therefore symptoms were not viewed as “bothersome.” As we did not 
interview patients who declined to take part in the trial, these results 
cannot be confirmed. However, during post- trial discussions with our 
cancer patient reference group, it was suggested that the use of the 
term “bothersome” may have been perceived by some patients as 
“complaining” (Yorke et al., 2015). Therefore, the screening question 
was changed to focus on daily activities that symptoms may interfere 
with: “Are you affected in your day- to- day life by breathlessness?” and 
repeated for each symptom. Research staff also suggested that the 
time frame between participant consent and delivery of the interven-
tion was too restrictive and difficult to adhere to. The reasons for this 
were valid: patients became ill during that time or were busy with other 
commitments. This presents challenges when designing controlled tri-
als as every effort is made to ensure that all participants are managed 
in a similar way. In the light of this, the timeframe between consent 
and delivery of the first RDSI session has been expanded to 2 weeks.
There was a perception that some patients agreed to participate 
in the trial, because it acknowledged and legitimised their symptoms 
to themselves, family/friends and healthcare providers. It was felt 
that participants who were post- curative intent treatment were often 
left to “get on with it”: taking part in the trial in contrast provided the 
opportunity to legitimise symptoms and take some control. In particu-
lar, patients and carers indicated that taking part in the trial increased 
their knowledge about lung cancer and their symptoms. The search for 
symptom legitimation is a familiar phenomenon in patients’ post- cancer 
treatment which can continue for several years (Rosman, 2009). In this 
study, the informed consent process appeared to provide an educa-
tional session about lung cancer and its associated symptoms. This 
suggests the need for targeted patient education by clinicians during 
and after cancer treatment and reinforced with patients in long- term 
follow- up when patients are likely to be experiencing a range of symp-
toms (Hofman, Ryan, Figueroa- Moseley, Jean- Pierre, & Morrow, 2007).
The specialist practitioners felt that available services for pallia-
tive and supportive care were not being fully utilised by clinical staff. 
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One focus group participant in particular, expressed disappointment 
that some clinicians regarded the trial intervention as only now having 
“something to offer our patients,” implying a lack of knowledge about 
available supportive services. It has been estimated that only approxi-
mately 15% of newly diagnosed lung cancer patients receive a referral 
to a breathlessness clinic at specialist centres, where such clinics exist 
(personal communication with Prof Miriam Johnson, based on pilot 
data for a breathlessness intervention study across five tertiary centres 
in the UK). This may, in part, relate to clinicians’ lack of awareness of 
the availability of palliative and support services for symptom manage-
ment (Wagland et al., 2012). However, this provides some evidence of 
the clinical need for an intervention like RDSI that can be delivered by 
a range of healthcare professionals who receive appropriate training.
Patients and carers expressed some discontent with the ques-
tionnaires and this was seen as a potential barrier to recruitment and 
retention. However, since the main RCT was a feasibility study the 
number of questionnaires was justified to enable the identification of 
the most useful measures for the planned follow- on trial. The research 
team also identified the amount of paper work as a barrier to recruit-
ment, but the importance of informed consent was noted as being 
essential for participant retention. Ensuring that potential research 
participants are fully informed about research expectations, includ-
ing paper work completion, forms part of the Good Clinical Practice 
training programme, and was adhered to in this study. For the follow- 
on trial, key outcome measures have been identified and participant 
response burden should reduce due to the decrease in the number of 
patient and carer- reported outcomes (Yorke et al., 2015).
Sensitivity is also required when informing patients and carers 
about the content of study questionnaires. It was apparent in the inter-
views that some participants found some items confronting and dis-
tressing. For some participants, the questionnaire items probed areas 
that they had not thought about or had chosen not to think about. 
Despite the decrease in the number of questionnaires to be used in 
the subsequent trial, there are likely to be some items in the retained 
questionnaires that may evoke a range of emotions and responses 
from participants. Although it is important to meet recruitment and 
questionnaire response rates, this needs to be balanced against the 
need to recruit fully informed participants and thereby meet accept-
able ethical principles (Hunt, Shlomo, & Addington- Hall, 2013).
Patients in this nested qualitative study who were randomised to 
the intervention arm appeared to find it acceptable and valuable, in 
some cases with unexpected benefits. In addition, some patients felt 
they were able to return to activities they had not undertaken for some 
time. Not all techniques suited all patients, however, they appeared to 
find the flexibility of choosing to utilise techniques relevant to what 
symptoms they were experiencing within the intervention beneficial. 
Flexibility, particularly with complex interventions that target a clus-
ter of symptoms has been previously identified as an important factor 
for patients with lung cancer (Ellis et al., 2012). The opportunity to 
implement intervention techniques as part of everyday routines was 
particularly welcomed—such as applying different RDSI techniques 
whilst “sitting in the bus shelter.” However, it was also acknowledged 
by patients and carers that learning the different techniques requires 
patience and persistence. It is important to inform patients that it 
takes time to learn the different techniques and for them to have an 
effect. Reinforcement was viewed as important but could be timely 
and costly to the Health Service. A potential alternative might be the 
addition of an instructional video.
Patients and carers did not generally appear to find the supplemen-
tary written information useful with some having forgotten they had 
received it. Likewise, specialist practitioners were not sure when and 
how to introduce the supplementary information with many partici-
pants feeling somewhat overwhelmed by the volume of information. 
For the subsequent trial, only the Macmillan booklets for breathlessness 
and fatigue will be provided. Participating specialist practitioners who 
were physiotherapists also suggested that the role of physical activity, 
especially in the management of fatigue and breathlessness, should be 
incorporated as a key component of RDSI rather than only appearing in 
the written information. Given the strong evidence base for structured 
activity in the management of cancer- related symptoms (Schwartz, 
Mori, Gao, Nail, & King, 2001; Speck, Courneya, Mâsse, Duval, & 
Schmitz, 2010) this has been added as a key component to RDSI.
The results of this study need to be seen in the light of its limitations. 
All of the interview participants who took part in the study had complet-
ed the trial. Had we been able to interview those who did not complete 
the trial, we may have a better understanding of the factors that had 
influenced this decision. Another limitation is that interviews were cross- 
sectional and at the end of the trial. Ideally, for a follow- on trial, patients 
who do not wish to take part should also be approached for interview as 
this may provide important information about successful implementa-
tion in practice. In addition, longitudinal interviews with both control and 
intervention group participants should be conducted as a way of explor-
ing the impact of interventions beyond statistical results and to identify 
important implementation strategies that are based on the experiences 
of those receiving the intervention (Farquhar et al., 2014).
5  | CONCLUSIONS
The findings from this nested qualitative study are important as they 
provide crucial insight into the views and perceptions of patients, car-
ers and researchers who participated in a RCT of the feasibility and 
acceptability of the RDSI for the management of breathlessness–
cough–fatigue in lung cancer patients. Informed by these qualitative 
insights, we have been able to improve and refine the intervention and 
trial processes in order to conduct a fully powered trial. Considering 
such findings will help ensure that the trial is person- centred and 
reflects the diverse needs and preferences of this particular popula-
tion in appropriate and sensitive ways.
ACKNOWLEDGEMENTS
This study was funded by a grant from Marie Curie Cancer Care (Ref: 
C16396/A14093). The authors are grateful to all patients who took 
time to take part in this study.
Ellis Et al.    |  11 of 11
REFERENCES
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Quali-
tative Research in Psychology, 3, 77–101.
Cheville, A. L., Novotny, P. J., Sloan, J. A., Basford, J. R., Wampfler, J. A., 
Garces, Y. I., … & Yang, P. (2011). Fatigue, dyspnea, and cough comprise 
a persistent symptom cluster up to five years after diagnosis with lung 
cancer. Journal of Pain and Symptom Management, 42, 202–212.
Department of Health (2006). A stronger local voice in the development of 
health and social care services. London: Author.
Donovan, J., Mills, N., Smith, M., Brindle, L., Jacoby, A., Peters, T., … & Ham-
dy, F. (2002). Quality improvement report: Improving design and con-
duct of randomised trials by embedding them in qualitative research: 
ProtecT (prostate testing for cancer and treatment) study. British Med-
ical Journal, 325, 766.
Ellis, J., Wagland, R., Tishelman, C., Williams, M. L., Bailey, C. D., Haines, J., 
… & Molassiotis, A. (2012). Considerations in developing and delivering 
a nonpharmacological intervention for symptom management in lung 
cancer: The views of patients and informal caregivers. Journal of Pain 
and Symptom Management, 44, 831–842.
Farquhar, M., Prevost, A., Mccrone, P., Brafman-Price, B., Bentley, A., Hig-
ginson, I., … & Booth, S. (2014). Is a specialist breathlessness service 
more effective and cost effective for patients with advanced cancer 
and their carers than standard care? Findings of a mixed- method ran-
domised controlled trial. BMC Medicine, 12, 194.
Hofman, M., Ryan, J. L., Figueroa-Moseley, C. D., Jean-Pierre, P., & Morrow, 
G. R. (2007). Cancer- related fatigue: The scale of the problem. The On-
cologist, 12, 4–10.
Hunt, K. J., Shlomo, N., & Addington-Hall, J. (2013). Participant recruitment 
in sensitive surveys: A comparative trial of ‘opt in’versus ‘opt out’ap-
proaches. BMC Medical Research Methodology, 13, 3.
Jordhøy, M. S., Kaasa, S., Fayers, P., Underland, G., & Ahlner-Elmqvist, M. 
(1999). Challenges in palliative care research; recruitment, attrition and 
compliance: Experience from a randomized controlled trial. Palliative 
Medicine, 13, 299–310.
Molassiotis, A., Lowe, M., Ellis, J., Wagland, R., Bailey, C., Lloyd-Williams, 
M., … & Smith, J. (2011). The experience of cough in patients diagnosed 
with lung cancer. Supportive Care in Cancer, 19, 1997–2004.
Molassiotis, A., Uyterlinde, W., Hollen, P. J., Sarna, L., Palmer, P., & Krishna-
samy, M. (2015). Supportive care in lung cancer: Milestones over the 
past 40 years. Journal of Thoracic Oncology, 10, 10–18.
Rosman, S. (2009). ‘Recovered from cancer but still ill’: Strategies used to 
legitimise extreme persistent fatigue in disease- free cancer patients. 
European Journal of Cancer Care, 18, 28–36.
Schofield, P., Ugalde, A., Carey, M., Mileshkin, L., Duffy, M., Ball, D., & 
Aranda, S. (2008). Lung cancer: Challenges and solutions for sup-
portive care intervention research. Palliative and Supportive Care, 6, 
281–287.
Schwartz, A. L., Mori, M., Gao, R., Nail, L. M., & King, M. E. (2001). Exercise 
reduces daily fatigue in women with breast cancer receiving chemo-
therapy. Medicine and Science in Sports and Exercise, 33, 718–723.
Speck, R. M., Courneya, K. S., Mâsse, L. C., Duval, S., & Schmitz, K. H. 
(2010). An update of controlled physical activity trials in cancer sur-
vivors: A systematic review and meta- analysis. Journal of Cancer Survi-
vorship, 4, 87–100.
Treweek, S., Altman, D. G., Bower, P., Campbell, M., Chalmers, I., Cotton, S., 
… & Clarke, M. (2015). Making randomised trials more efficient: Report 
of the first meeting to discuss the trial forge platform. Trials, 16, 261
Wagland, R., Ellis, J., Bailey, C. D., Haines, J., Caress, A., Williams, M. L., … 
& Molassiotis, A. (2012). Considerations in developing and delivering 
a non- pharmacological intervention for symptom management in lung 
cancer: The views of health care professionals. Supportive Care in Can-
cer, 20, 2565–2574.
Yates, P., Schofield, P., Zhao, I., & Currow, D. (2013). Supportive and pallia-
tive care for lung cancer patients. Journal of Thoracic Disease, 5, S623.
Yorke, J., Lloyd-Williams, M., Smith, J., Blackhall, F., Harle, A., Warden, J., … 
& Molassiotis, A. (2015). Management of the respiratory distress symp-
tom cluster in lung cancer: A randomised controlled feasibility trial. 
Supportive Care in Cancer, 23, 3373–3384.
Zhao, I., & Yates, P. (2008). Non- pharmacological interventions for breath-
lessness management in patients with lung cancer: A systematic re-
view. Palliative Medicine, 22, 693–701.
How to cite this article: Ellis J, Warden J, Molassiotis A, et al. 
Participation in a randomised controlled feasibility study of a 
complex intervention for the management of the Respiratory 
Symptom Distress Cluster in lung cancer: patient, carer and 
research staff views. Eur J Cancer Care. 2017;26:e12538.  
https://doi.org/10.1111/ecc.12538
